Crawford ends year on high with Queen’s gong and 17% revenue growth

ADVANCED wound care and dermatology specialist Crawford Healthcare has followed up its Queens Award for Enterprise: International Trade 2016 by celebrating a 17% increase in revenue to £21.5m.

Accounts for the year ended March 31 highlight the Knutsford, Cheshire company’s increasingly profitable operations in the US and Europe.

UK turnover went up 12%to £19.4m (2015: £17.3m) and in the US it rose 82% to £2m (2015: £1.1m).

Adjusted UK EBITDA grew 27% to £5.2m (2015: £4.1m).

In addition to the Queen’s Award, the company has secured exclusive rights to develop wound care products incorporating the fastest and most powerful antimicrobial treatment available globally.

2015/16 also saw Crawford become the largest SME within the advanced wound care market, reflecting average annual sales growth of 41% over the last three years.

Chief executive Richard Anderson said: “In terms of innovation, Crawford is a leading international healthcare business, and in 2015/16 we have significantly accelerated our growth.

“Our strategic entry into advanced wound care via acquisition in 2011 is proving to be extremely successful for the group and has been a major catalyst for our growth – from a business at acquisition selling less than £2.5m, our wound care operation is currently the fourth largest in the UK.”